Express Pharma - Express Pharma

To make clinical R&D sector in India survive and grow, the government should become more practical in its approach while…

Asks sponsor to provide details of payment to investigators

Triples the production capacity for hormonal products

Are indicated for short-term treatment for healing and symptom relief of active duodenal ulcer

To treat colorectal and breast cancers

To develop a novel class of antibiotics, a new strategic therapeutic area for Debiopharm

To market CytoSorb, a‘first-in-class’ therapy for Sepsis management

Application filed to US FDA for generic version of Absorica

Is indicated for relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

To promote Locoid lotion to US pediatricians